/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
EUR/USD
-0.66%
Natural Gas
+0.14%
Gold
-1.38%
BTC
-1.64%
ETH
-1.91%
SPX
+1.47%
VIX
+4.81%
Economic Calendar
EUR/USD
-0.66%
Natural Gas
+0.14%
Gold
-1.38%
BTC
-1.64%
ETH
-1.91%
SPX
+1.47%
VIX
+4.81%
Economic Calendar
BTC
-1.64%
ETH
-1.91%
XRP
-1.41%
ADA
-1.18%
SOL
-2.58%
Review
Review
Review
Fed seen more likely to lift rates above 5% after strong jobs report
10 minutes ago
World Bank resumed parallel proceedings on concern over Indus Water Treaty – spokesman
11 minutes ago
Dollar jumps as employers add more jobs than expected in January
12 minutes ago
Brazil’s industrial output falls in 2022, gloomy scenario likely to continue
12 minutes ago
Futures slide as blowout Jan jobs data adds to rate hike worries
12 minutes ago
U.S. job growth accelerates in January, wage gains moderate
11 minutes ago
Disappointing Earnings vs Dovish Central Bank Talks
about 1 hour ago
Oil Price Fundamental Daily Forecast – Sideways-to-Lower Trade Tied to Uncertainty Over EU Embargo, Price Caps
41 minutes ago
Gold Price Forecast XAU/USD – Weak NFP Data Will Support Case for Fed Ending Rate Hikes in March
about 2 hours ago
U.S. Dollar Index (DX) Futures Technical Analysis – Bears Hoping for Signs of a Loosening Labor Market
about 3 hours ago
AUDUSD Forecast – Momentum Trending Lower Ahead of NFP Report
about 5 hours ago
ETH to Retarget $1,750 on US Jobs Report and Shanghai Hard Fork News
about 2 hours ago
Quick Links
:
Forecasts
Economic Calendar
Crypto
Commodities
FXTM Academy
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
BIIB
profile
Biogen Inc
Follow
BIIB
(
Nasdaq - US
)
Closed
287.34
-4.26 (-1.46%)
in
:
usd
•
As of: Feb 02, 2023 15:59
UTC -5
Open
290.06
High
293.14
Low
285.75
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
About
Biogen Inc
CEO
Michel Vounatsos
Headquarters
225 binney street
cambridge, ma 02142, united states
Auditor
PricewaterhouseCoopers LLP
Employees
9,610
Share Holders
479
Website
www.biogen.com
Industry
biotechnology
Sector
health technology
Company Overview
Biogen Inc. is one of the world's leading biotechnology companies which focuses on developing innovative therapies for treating serious neurological and neurodegenerative diseases, including its core growth areas of multiple sclerosis (MS) and neuroimmunology, Alzheimer's disease (AD) and dementia, movement disorders including Parkinson's disease, neuromuscular disorders, including spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS) and ophthalmology. Key multiple sclerosis/MS drugs in its portfolio are Tecfidera, Vumerity, Avonex, Plegridy, Fampyra and Tysabri. Other approved/marketed products include Fumaderm (severe psoriasis), Spinraza (spinal muscular atrophy (SMA)) and Aduhelm (Alzheimer's disease).
Biogen Inc
Statistics
Valuation Measures
Market Capitalization
2
41.38B
Enterprise Value
43.98B
Enterprise Value/EBITDA
(ttm)
11.31
Price to Earnings Ratio
(ttm)
17.12
Price to Book
(mrq)
3.29
Price to Sales
(ttm)
4.05
Price to Cash
(ytd)
10.73
Profitability
Gross Margin
(ttm)
77.17%
Operating Margin
(ttm)
24.06%
Profit Margin
(ttm)
27.89%
Return on Equity
(ttm)
21.31%
Return on Invested Capital
(ttm)
12.92%
Return on Assets
(ttm)
10.24%
Income Statement
Revenue
(ttm)
10.36B
Revenue Per Share
(ttm)
71.97
Gross Profit
(ttm)
8.00B
EBITDA
(ttm)
3
3.89B
Net Income Avi to Common
(ttm)
2.86B
Diluted EPS
(ttm)
19.64
Share Statistics
Beta (5Y Monthly)
0.22
52-Week Change
30.51%
S&P500 52-Week Change
-6.65%
S&P500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding
1
144.00M
Dividend Yield
0.00%
Float
4
143.06M
%
Held by Insiders
0.65%
%
Held by Institutions
84.40%
Balance Sheet
Total Cash
(mrq)
4.91B
Total Cash Per Share
(mrq)
34.10
Total Debt
(mrq)
6.28B
Total Debt/Equity
(mrq)
49.18%
Current Ratio
(mrq)
2.49%
Quick Ratio
(mrq)
2.14%
Book Value Per Share
(mrq)
88.66
Cash Flow
Operating Cash Flow Per Share
(ytd)
10.77
Free Cash Flow
(ytd)
1.99B
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker